LASR 10-Q Quarterly Report June 30, 2021 | Alphaminr
ALPHAMINR

LASR 10-Q Quarter ended June 30, 2021

Balance Sheet
Cash Flow
Income Statement
NLIGHT, INC.
lasr-20210630
0001124796 12/31 2021 Q2 FALSE 0001124796 2021-01-01 2021-06-30 xbrli:shares 0001124796 2021-08-03 iso4217:USD 0001124796 2021-06-30 0001124796 2020-12-31 iso4217:USD xbrli:shares 0001124796 us-gaap:ProductMember 2021-04-01 2021-06-30 0001124796 us-gaap:ProductMember 2020-04-01 2020-06-30 0001124796 us-gaap:ProductMember 2021-01-01 2021-06-30 0001124796 us-gaap:ProductMember 2020-01-01 2020-06-30 0001124796 lasr:DevelopmentMember 2021-04-01 2021-06-30 0001124796 lasr:DevelopmentMember 2020-04-01 2020-06-30 0001124796 lasr:DevelopmentMember 2021-01-01 2021-06-30 0001124796 lasr:DevelopmentMember 2020-01-01 2020-06-30 0001124796 2021-04-01 2021-06-30 0001124796 2020-04-01 2020-06-30 0001124796 2020-01-01 2020-06-30 0001124796 us-gaap:CommonStockMember 2021-03-31 0001124796 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001124796 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001124796 us-gaap:RetainedEarningsMember 2021-03-31 0001124796 2021-03-31 0001124796 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001124796 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001124796 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001124796 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001124796 us-gaap:CommonStockMember 2021-06-30 0001124796 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001124796 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001124796 us-gaap:RetainedEarningsMember 2021-06-30 0001124796 us-gaap:CommonStockMember 2020-12-31 0001124796 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001124796 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001124796 us-gaap:RetainedEarningsMember 2020-12-31 0001124796 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001124796 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001124796 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001124796 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-06-30 0001124796 us-gaap:CommonStockMember 2020-03-31 0001124796 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001124796 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001124796 us-gaap:RetainedEarningsMember 2020-03-31 0001124796 2020-03-31 0001124796 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001124796 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001124796 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001124796 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001124796 us-gaap:CommonStockMember 2020-06-30 0001124796 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001124796 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001124796 us-gaap:RetainedEarningsMember 2020-06-30 0001124796 2020-06-30 0001124796 us-gaap:CommonStockMember 2019-12-31 0001124796 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001124796 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001124796 us-gaap:RetainedEarningsMember 2019-12-31 0001124796 2019-12-31 0001124796 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0001124796 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001124796 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0001124796 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-06-30 0001124796 lasr:OPIPhotonicsMember 2020-07-30 2020-07-30 0001124796 lasr:OPIPhotonicsMember 2021-04-01 2021-06-30 0001124796 lasr:OPIPhotonicsMember 2021-01-01 2021-06-30 0001124796 lasr:IndustrialMember 2021-04-01 2021-06-30 0001124796 lasr:IndustrialMember 2020-04-01 2020-06-30 0001124796 lasr:IndustrialMember 2021-01-01 2021-06-30 0001124796 lasr:IndustrialMember 2020-01-01 2020-06-30 0001124796 lasr:MicrofabricationMember 2021-04-01 2021-06-30 0001124796 lasr:MicrofabricationMember 2020-04-01 2020-06-30 0001124796 lasr:MicrofabricationMember 2021-01-01 2021-06-30 0001124796 lasr:MicrofabricationMember 2020-01-01 2020-06-30 0001124796 lasr:AerospaceandDefenseMember 2021-04-01 2021-06-30 0001124796 lasr:AerospaceandDefenseMember 2020-04-01 2020-06-30 0001124796 lasr:AerospaceandDefenseMember 2021-01-01 2021-06-30 0001124796 lasr:AerospaceandDefenseMember 2020-01-01 2020-06-30 0001124796 srt:NorthAmericaMember 2021-04-01 2021-06-30 0001124796 srt:NorthAmericaMember 2020-04-01 2020-06-30 0001124796 srt:NorthAmericaMember 2021-01-01 2021-06-30 0001124796 srt:NorthAmericaMember 2020-01-01 2020-06-30 0001124796 country:CN 2021-04-01 2021-06-30 0001124796 country:CN 2020-04-01 2020-06-30 0001124796 country:CN 2021-01-01 2021-06-30 0001124796 country:CN 2020-01-01 2020-06-30 0001124796 lasr:RestofWorldExcludingChinaandNorthAmericaMember 2021-04-01 2021-06-30 0001124796 lasr:RestofWorldExcludingChinaandNorthAmericaMember 2020-04-01 2020-06-30 0001124796 lasr:RestofWorldExcludingChinaandNorthAmericaMember 2021-01-01 2021-06-30 0001124796 lasr:RestofWorldExcludingChinaandNorthAmericaMember 2020-01-01 2020-06-30 0001124796 us-gaap:TransferredAtPointInTimeMember 2021-04-01 2021-06-30 0001124796 us-gaap:TransferredAtPointInTimeMember 2020-04-01 2020-06-30 0001124796 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-06-30 0001124796 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-06-30 0001124796 us-gaap:TransferredOverTimeMember 2021-04-01 2021-06-30 0001124796 us-gaap:TransferredOverTimeMember 2020-04-01 2020-06-30 0001124796 us-gaap:TransferredOverTimeMember 2021-01-01 2021-06-30 0001124796 us-gaap:TransferredOverTimeMember 2020-01-01 2020-06-30 xbrli:pure 0001124796 lasr:U.S.GovernmentMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-04-01 2021-06-30 0001124796 lasr:U.S.GovernmentMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-04-01 2020-06-30 0001124796 lasr:U.S.GovernmentMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-06-30 0001124796 lasr:U.S.GovernmentMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-06-30 0001124796 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember lasr:QuickLaserTechnologyCoLtdMember 2020-04-01 2020-06-30 0001124796 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember lasr:QuickLaserTechnologyCoLtdMember 2020-01-01 2020-06-30 0001124796 lasr:RaytheonTechnologiesMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-04-01 2020-06-30 0001124796 lasr:RaytheonTechnologiesMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-06-30 0001124796 lasr:TwoCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-06-30 0001124796 lasr:TwoCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001124796 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2021-06-30 0001124796 us-gaap:FairValueInputsLevel2Member us-gaap:MoneyMarketFundsMember 2021-06-30 0001124796 us-gaap:FairValueInputsLevel3Member us-gaap:MoneyMarketFundsMember 2021-06-30 0001124796 us-gaap:MoneyMarketFundsMember 2021-06-30 0001124796 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member 2021-06-30 0001124796 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member 2021-06-30 0001124796 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialPaperMember 2021-06-30 0001124796 us-gaap:CommercialPaperMember 2021-06-30 0001124796 us-gaap:FairValueInputsLevel1Member 2021-06-30 0001124796 us-gaap:FairValueInputsLevel2Member 2021-06-30 0001124796 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001124796 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2020-12-31 0001124796 us-gaap:FairValueInputsLevel2Member us-gaap:MoneyMarketFundsMember 2020-12-31 0001124796 us-gaap:FairValueInputsLevel3Member us-gaap:MoneyMarketFundsMember 2020-12-31 0001124796 us-gaap:MoneyMarketFundsMember 2020-12-31 0001124796 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001124796 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001124796 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialPaperMember 2020-12-31 0001124796 us-gaap:CommercialPaperMember 2020-12-31 0001124796 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001124796 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001124796 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001124796 us-gaap:AutomobilesMember 2021-01-01 2021-06-30 0001124796 us-gaap:AutomobilesMember 2021-06-30 0001124796 us-gaap:AutomobilesMember 2020-12-31 0001124796 lasr:ComputerHardwareAndSoftwareMember srt:MinimumMember 2021-01-01 2021-06-30 0001124796 srt:MaximumMember lasr:ComputerHardwareAndSoftwareMember 2021-01-01 2021-06-30 0001124796 lasr:ComputerHardwareAndSoftwareMember 2021-06-30 0001124796 lasr:ComputerHardwareAndSoftwareMember 2020-12-31 0001124796 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-06-30 0001124796 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-06-30 0001124796 us-gaap:MachineryAndEquipmentMember 2021-06-30 0001124796 us-gaap:MachineryAndEquipmentMember 2020-12-31 0001124796 srt:MinimumMember lasr:OfficeEquipmentAndFurnitureMember 2021-01-01 2021-06-30 0001124796 srt:MaximumMember lasr:OfficeEquipmentAndFurnitureMember 2021-01-01 2021-06-30 0001124796 lasr:OfficeEquipmentAndFurnitureMember 2021-06-30 0001124796 lasr:OfficeEquipmentAndFurnitureMember 2020-12-31 0001124796 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-06-30 0001124796 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-06-30 0001124796 us-gaap:LeaseholdImprovementsMember 2021-06-30 0001124796 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001124796 us-gaap:BuildingMember 2021-01-01 2021-06-30 0001124796 us-gaap:BuildingMember 2021-06-30 0001124796 us-gaap:BuildingMember 2020-12-31 0001124796 us-gaap:LandMember 2021-06-30 0001124796 us-gaap:LandMember 2020-12-31 0001124796 us-gaap:PatentsMember srt:MinimumMember 2021-01-01 2021-06-30 0001124796 srt:MaximumMember us-gaap:PatentsMember 2021-01-01 2021-06-30 0001124796 us-gaap:PatentsMember 2021-06-30 0001124796 us-gaap:PatentsMember 2020-12-31 0001124796 us-gaap:CustomerRelatedIntangibleAssetsMember srt:MinimumMember 2021-01-01 2021-06-30 0001124796 srt:MaximumMember us-gaap:CustomerRelatedIntangibleAssetsMember 2021-01-01 2021-06-30 0001124796 us-gaap:CustomerRelatedIntangibleAssetsMember 2021-06-30 0001124796 us-gaap:CustomerRelatedIntangibleAssetsMember 2020-12-31 0001124796 us-gaap:DevelopedTechnologyRightsMember 2021-01-01 2021-06-30 0001124796 us-gaap:DevelopedTechnologyRightsMember 2021-06-30 0001124796 us-gaap:DevelopedTechnologyRightsMember 2020-12-31 0001124796 lasr:LaserProductsMember 2020-12-31 0001124796 lasr:AdvancedDevelopmentMember 2020-12-31 0001124796 lasr:LaserProductsMember 2021-01-01 2021-06-30 0001124796 lasr:AdvancedDevelopmentMember 2021-01-01 2021-06-30 0001124796 lasr:LaserProductsMember 2021-06-30 0001124796 lasr:AdvancedDevelopmentMember 2021-06-30 0001124796 srt:MinimumMember lasr:OperatingLeasesExcludingAutomobilesMember 2021-06-30 0001124796 srt:MaximumMember lasr:OperatingLeasesExcludingAutomobilesMember 2021-06-30 0001124796 lasr:OperatingLeasesExcludingAutomobilesMember 2021-06-30 0001124796 srt:MinimumMember lasr:OperatingLeasesAutomobilesMember 2021-06-30 0001124796 srt:MaximumMember lasr:OperatingLeasesAutomobilesMember 2021-06-30 0001124796 lasr:FollowOnPublicOfferingMember 2021-03-01 2021-03-31 0001124796 lasr:FollowOnPublicOfferingPortionFromUnderwritersOptionMember 2021-03-01 2021-03-31 0001124796 lasr:FollowOnPublicOfferingMember 2021-06-30 0001124796 us-gaap:RestrictedStockMember 2020-12-31 0001124796 us-gaap:RestrictedStockMember 2021-01-01 2021-06-30 0001124796 us-gaap:RestrictedStockMember 2021-06-30 0001124796 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001124796 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0001124796 us-gaap:RestrictedStockUnitsRSUMember 2021-06-30 0001124796 lasr:PerformanceRestrictedStockAwardsAndPerformanceRestrictedStockUnitsMember 2021-06-30 0001124796 2020-01-01 2020-12-31 0001124796 us-gaap:CostOfSalesMember 2021-04-01 2021-06-30 0001124796 us-gaap:CostOfSalesMember 2020-04-01 2020-06-30 0001124796 us-gaap:CostOfSalesMember 2021-01-01 2021-06-30 0001124796 us-gaap:CostOfSalesMember 2020-01-01 2020-06-30 0001124796 us-gaap:ResearchAndDevelopmentExpenseMember 2021-04-01 2021-06-30 0001124796 us-gaap:ResearchAndDevelopmentExpenseMember 2020-04-01 2020-06-30 0001124796 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-06-30 0001124796 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-06-30 0001124796 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-04-01 2021-06-30 0001124796 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-04-01 2020-06-30 0001124796 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-06-30 0001124796 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-06-30 0001124796 2019-11-14 lasr:segment 0001124796 lasr:LaserProductsMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0001124796 lasr:AdvancedDevelopmentMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0001124796 us-gaap:CorporateNonSegmentMember 2021-04-01 2021-06-30 0001124796 lasr:LaserProductsMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0001124796 lasr:AdvancedDevelopmentMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0001124796 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-06-30 0001124796 lasr:LaserProductsMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0001124796 lasr:AdvancedDevelopmentMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0001124796 us-gaap:CorporateNonSegmentMember 2020-04-01 2020-06-30 0001124796 lasr:LaserProductsMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0001124796 lasr:AdvancedDevelopmentMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0001124796 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-06-30 0001124796 lasr:RestrictedStockAndRestrictedStockUnitsMember 2021-04-01 2021-06-30 0001124796 lasr:RestrictedStockAndRestrictedStockUnitsMember 2020-04-01 2020-06-30 0001124796 lasr:RestrictedStockAndRestrictedStockUnitsMember 2021-01-01 2021-06-30 0001124796 lasr:RestrictedStockAndRestrictedStockUnitsMember 2020-01-01 2020-06-30 0001124796 us-gaap:EmployeeStockMember 2021-04-01 2021-06-30 0001124796 us-gaap:EmployeeStockMember 2020-04-01 2020-06-30 0001124796 us-gaap:EmployeeStockMember 2021-01-01 2021-06-30 0001124796 us-gaap:EmployeeStockMember 2020-01-01 2020-06-30 0001124796 us-gaap:StockOptionMember 2021-04-01 2021-06-30 0001124796 us-gaap:StockOptionMember 2020-04-01 2020-06-30 0001124796 us-gaap:StockOptionMember 2021-01-01 2021-06-30 0001124796 us-gaap:StockOptionMember 2020-01-01 2020-06-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________
FORM 10-Q
________________________________________________________
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2021
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number 001-38462
________________________________________________________
NLIGHT, INC.
(Exact name of Registrant as specified in its charter)
________________________________________________________
Delaware 91-2066376
(State or other jurisdiction of
incorporation or organization) 		(I.R.S. Employer
Identification Number)
4637 NW 18 th Avenue
Camas , Washington 98607
(Address of principal executive office, including zip code)
( 360 ) 566-4460
(Registrant's telephone number, including area code)
__________________________________________

Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class Trading Symbol Name of Exchange on which Registered
Common Stock, par value
$0.0001 per share 		LASR The Nasdaq Stock Market LLC

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer ☒ Accelerated Filer ☐ Non-Accelerated Filer ☐ Smaller Reporting Company ☐
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.         ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes ☐ No ☒

As of August 3, 2021, the Registrant had 43,198,143 shares of common stock outstanding.


TABLE OF CONTENTS
Page




PART I - FINANCIAL INFORMATION

ITEM 1. UNAUDITED INTERIM FINANCIAL STATEMENTS

nLIGHT, Inc.
Consolidated Balance Sheets
(In thousands)
(Unaudited)
As of
June 30, 2021 December 31, 2020
Assets
Current assets:
Cash and cash equivalents $ 175,364 $ 102,282
Accounts receivable, net of allowances of $ 298 and $ 367
36,829 31,820
Inventory 63,296 54,706
Prepaid expenses and other current assets 11,568 11,767
Total current assets 287,057 200,575
Restricted cash 250 291
Lease right-of-use assets 17,887 12,302
Property, plant and equipment, net of accumulated depreciation of
$ 70,216 and $ 66,262
49,378 44,480
Intangible assets, net of accumulated amortization of $ 7,693 and $ 6,280
6,519 8,345
Goodwill 12,457 12,484
Other assets, net 5,026 5,167
Total assets $ 378,574 $ 283,644
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable $ 25,677 $ 21,057
Accrued liabilities 15,564 15,321
Deferred revenues 2,666 2,528
Current portion of lease liabilities 2,921 2,273
Current portion of long-term debt — 184
Total current liabilities 46,828 41,363
Non-current income taxes payable 6,882 7,556
Long-term lease liabilities 15,505 10,375
Long-term debt 30 215
Other long-term liabilities 4,683 4,221
Total liabilities 73,928 63,730
Stockholders' equity:
Common stock - $ 0.0001 par value; 190,000 shares authorized, 43,181 shares issued and outstanding at June 30, 2021, and 39,793 shares issued and outstanding at December 31, 2020
15 15
Additional paid-in capital 457,480 358,544
Accumulated other comprehensive loss ( 424 ) ( 259 )
Accumulated deficit ( 152,425 ) ( 138,386 )
Total stockholders’ equity 304,646 219,914
Total liabilities and stockholders’ equity $ 378,574 $ 283,644

See accompanying notes to consolidated financial statements.
1
nLIGHT, Inc.
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)

Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
Revenue:
Products $ 53,561 $ 45,104 $ 100,896 $ 82,034
Development 15,552 7,034 29,562 13,319
Total revenue 69,113 52,138 130,458 95,353
Cost of revenue:
Products 34,240 32,597 64,635 60,497
Development 14,548 6,485 27,853 12,299
Total cost of revenue 48,788 39,082 92,488 72,796
Gross profit 20,325 13,056 37,970 22,557
Operating expenses:
Research and development 14,282 9,472 25,992 18,010
Sales, general, and administrative 15,057 9,633 26,771 17,333
Total operating expenses 29,339 19,105 52,763 35,343
Loss from operations ( 9,014 ) ( 6,049 ) ( 14,793 ) ( 12,786 )
Other income (expense):
Interest income (expense), net ( 32 ) ( 65 ) ( 106 ) 218
Other income (expense), net 118 ( 298 ) 144 ( 414 )
Loss before income taxes ( 8,928 ) ( 6,412 ) ( 14,755 ) ( 12,982 )
Income tax expense (benefit) ( 1,038 ) 418 ( 716 ) 1,323
Net loss $ ( 7,890 ) $ ( 6,830 ) $ ( 14,039 ) $ ( 14,305 )
Net loss per share, basic and diluted $ ( 0.19 ) $ ( 0.18 ) $ ( 0.34 ) $ ( 0.38 )
Shares used in per share calculations, basic and diluted 42,313 38,177 41,187 38,003

See accompanying notes to consolidated financial statements.

2
nLIGHT, Inc.
Consolidated Statements of Comprehensive Loss
(In thousands)
(Unaudited)

Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
Net loss $ ( 7,890 ) $ ( 6,830 ) $ ( 14,039 ) $ ( 14,305 )
Other comprehensive loss:
Foreign currency translation adjustments, net of tax 497 333 ( 165 ) ( 163 )
Comprehensive loss $ ( 7,393 ) $ ( 6,497 ) $ ( 14,204 ) $ ( 14,468 )

See accompanying notes to consolidated financial statements.

3
nLIGHT, Inc.
Consolidated Statements of Stockholders' Equity
(In thousands)
(Unaudited)
Three Months Ended June 30, 2021
Common stock Additional paid-in capital Accumulated other comprehensive loss Accumulated deficit Total stockholders' equity
Shares Amount
Balance, March 31, 2021 42,783 $ 15 $ 449,496 $ ( 921 ) $ ( 144,535 ) $ 304,055
Net loss — — — — ( 7,890 ) ( 7,890 )
Offering costs — — ( 1 ) — — ( 1 )
Issuance of common stock pursuant to exercise of stock options 101 — 196 — — 196
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax 264 — ( 4,567 ) — — ( 4,567 )
Issuance of common stock under the Employee Stock Purchase Plan 33 — 750 — — 750
Stock-based compensation — — 11,606 — — 11,606
Cumulative translation adjustment, net of tax — — — 497 — 497
Balance, June 30, 2021 43,181 $ 15 $ 457,480 $ ( 424 ) $ ( 152,425 ) $ 304,646

Six Months Ended June 30, 2021
Common stock Additional paid-in capital Accumulated other comprehensive loss Accumulated deficit Total stockholders' equity
Shares Amount
Balance, December 31, 2020 39,793 $ 15 $ 358,544 $ ( 259 ) $ ( 138,386 ) $ 219,914
Net loss — — — — ( 14,039 ) ( 14,039 )
Proceeds from follow-on offering, net of offering costs 2,537 — 82,354 — — 82,354
Issuance of common stock pursuant to exercise of stock options 553 — 770 — — 770
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax 265 — ( 4,598 ) — — ( 4,598 )
Issuance of common stock under the Employee Stock Purchase Plan 33 — 750 — — 750
Stock-based compensation — — 19,660 — — 19,660
Cumulative translation adjustment, net of tax — — — ( 165 ) — ( 165 )
Balance, June 30, 2021 43,181 $ 15 $ 457,480 $ ( 424 ) $ ( 152,425 ) $ 304,646

4
Three Months Ended June 30, 2020
Common stock Additional paid-in capital Accumulated other comprehensive loss Accumulated deficit Total stockholders' equity
Shares Amount
Balance, March 31, 2020 38,473 $ 15 $ 341,042 $ ( 3,181 ) $ ( 124,929 ) $ 212,947
Net loss — — — — ( 6,830 ) ( 6,830 )
Issuance of common stock pursuant to exercise of stock options 145 — 299 — — 299
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax 193 — ( 2,146 ) — — ( 2,146 )
Issuance of common stock under the Employee Stock Purchase Plan 39 — 685 — — 685
Stock-based compensation — — 6,037 — — 6,037
Cumulative translation adjustment, net of tax — — — 333 — 333
Balance, June 30, 2020 38,850 $ 15 $ 345,917 $ ( 2,848 ) $ ( 131,759 ) $ 211,325


Six Months Ended June 30, 2020
Common stock Additional paid-in capital Accumulated other comprehensive loss Accumulated deficit Total stockholders' equity
Shares Amount
Balance, December 31, 2019 38,084 $ 15 $ 336,732 $ ( 2,685 ) $ ( 117,454 ) $ 216,608
Net loss — — — — ( 14,305 ) ( 14,305 )
Issuance of common stock pursuant to exercise of stock options 518 — 857 — — 857
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax 209 — ( 2,157 ) — — ( 2,157 )
Issuance of common stock under the Employee Stock Purchase Plan 39 — 685 — — 685
Stock-based compensation — — 9,800 — — 9,800
Cumulative translation adjustment, net of tax — — — ( 163 ) — ( 163 )
Balance, June 30, 2020 38,850 $ 15 $ 345,917 $ ( 2,848 ) $ ( 131,759 ) $ 211,325

See accompanying notes to consolidated financial statements.
5
nLIGHT, Inc.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Six Months Ended June 30,
2021 2020
Cash flows from operating activities:
Net loss $ ( 14,039 ) $ ( 14,305 )
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation 4,290 3,614
Amortization 3,122 2,815
Reduction in carrying amount of right-of-use assets 1,632 1,425
Provision for (recoveries of) losses on accounts receivable ( 72 ) 62
Stock-based compensation 19,660 9,800
Deferred income taxes ( 11 ) —
Loss on disposal of assets 3 —
Changes in operating assets and liabilities:
Accounts receivable, net ( 4,849 ) 3,012
Inventory ( 8,611 ) ( 4,457 )
Prepaid expenses and other current assets 175 ( 1,801 )
Other assets ( 905 ) ( 2,131 )
Accounts payable 3,335 7,400
Accrued and other long-term liabilities 1,347 1,243
Deferred revenues 133 1,519
Lease liabilities ( 1,404 ) ( 1,428 )
Non-current income taxes payable ( 721 ) 234
Net cash provided by operating activities 3,085 7,002
Cash flows from investing activities:
Acquisition of business, net of cash acquired ( 291 ) —
Purchases of property, plant and equipment ( 7,962 ) ( 17,040 )
Capitalization of patents ( 216 ) ( 628 )
Net cash used in investing activities ( 8,469 ) ( 17,668 )
Cash flows from financing activities:
Proceeds from public offerings, net of offering costs 82,354 —
Proceeds from term loan — 15,000
Principal payments on debt and financing leases ( 399 ) ( 45 )
Payment of contingent consideration related to acquisition ( 326 ) —
Proceeds from employee stock plan purchases 750 685
Proceeds from stock option exercises 770 857
Tax payments related to stock award issuances ( 4,598 ) ( 2,157 )
Net cash provided by financing activities 78,551 14,340
Effect of exchange rate changes on cash ( 126 ) ( 27 )
Net increase in cash, cash equivalents, and restricted cash 73,041 3,647
Cash, cash equivalents, and restricted cash, beginning of period 102,573 117,293
Cash, cash equivalents, and restricted cash, end of period $ 175,614 $ 120,940
Supplemental disclosures:
Cash paid (received) for interest, net $ 103 $ ( 316 )
Cash paid for income taxes 393 1,015
Right-of-use assets obtained in exchange for lease liabilities 7,224 12,408
Accrued purchases of property, equipment and patents 2,139 993

See accompanying notes to consolidated financial statements.
6
nLIGHT, Inc.
Notes to Consolidated Financial Statements
(Unaudited)
Note 1 - Basis of Presentation and New Accounting Pronouncements
Basis of Presentation
The accompanying consolidated financial statements of nLIGHT, Inc. and our wholly owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). The unaudited financial information reflects, in the opinion of management, all adjustments necessary for a fair presentation of financial position, results of operations, stockholders’ equity, and cash flows for the interim periods presented. The results reported for the interim period presented are not necessarily indicative of results that may be expected for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our 2020 Annual Report on Form 10-K.

Critical Accounting Policies
Our critical accounting policies have not materially changed during the six months ended June 30, 2021 from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020.

New Accounting Pronouncements

ASU 2016-13, ASU 2018-19, ASU 2019-04, ASU 2019-05 and ASU 2020-03
The Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , in June 2016. ASU 2016-13 replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For assets measured at amortized cost, the new standard requires that the income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. ASU 2016-13 was amended in November 2018, April 2019 and March 2020. We adopted ASU 2016-13, as amended, on January 1, 2021 on a prospective basis. The adoption did not have a material impact on our financial position, results of operations or cash flows.

ASU 2019-12
The FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , in December 2019. ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. We adopted ASU 2019-12 on January 1, 2021 on a prospective basis. The adoption did not have a material impact on our financial position, results of operations or cash flows.

Note 2 - Acquisitions
OPI
On July 30, 2020, we acquired the outstanding shares of OPI Photonics S.r.l. (OPI), an Italian limited liability company, for cash consideration of approximately $ 1.6 million, of which $ 0.2 million was paid at closing with the remaining $ 1.4 million to be paid over the next 24 months. The acquisition price was allocated to the tangible and identified intangible assets acquired and liabilities assumed as of the closing date of the acquisition based upon their respective fair values, and the excess of purchase price over the fair value amounts representing goodwill. The fair values assigned to assets acquired and liabilities assumed were based on management’s best estimates and assumptions as of the reporting date and are considered preliminary. Changes to amounts recorded as assets or liabilities may result in corresponding adjustments to goodwill. Pro forma financial information has not been provided for the purchase as it was not material to our overall financial position.

During the three and six months ended June 30, 2021, accrued acquisition consideration of $ 0.3 million and $ 0.6 million, respectively, was paid to the sellers of OPI.
7

Note 3 - Revenue

The following tables represent a disaggregation of revenue from contracts with customers for the periods presented (in thousands):
Sales by End Market
Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
Industrial $ 24,907 $ 22,630 $ 46,307 $ 38,620
Microfabrication 20,274 14,300 35,489 24,719
Aerospace and Defense 23,932 15,208 48,662 32,014
$ 69,113 $ 52,138 $ 130,458 $ 95,353

Sales by Geography
Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
North America $ 33,095 $ 20,494 $ 64,229 $ 41,540
China 18,759 21,495 34,336 33,537
Rest of World 17,259 10,149 31,893 20,276
$ 69,113 $ 52,138 $ 130,458 $ 95,353

Sales by Timing of Revenue
Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
Point in time $ 50,123 $ 45,273 $ 97,117 $ 82,203
Over time 18,990 6,865 33,341 13,150
$ 69,113 $ 52,138 $ 130,458 $ 95,353

Our contract assets and liabilities are as follows (in thousands):
Balance Sheet Classification As of
June 30, 2021 December 31, 2020
Contract assets Prepaid expenses and
other current assets 		$ 6,880 $ 5,680
Contract liabilities Deferred revenue and other long-term liabilities 3,152 2,985

During the three and six months ended June 30, 2021, we recognized revenue of $ 2.3 million and $ 3.7 million, respectively, that was included in the deferred revenue balances at the beginning of the periods as the performance obligations under the associated agreements were satisfied.

8
Note 4 - Concentrations of Credit and Other Risks
The following customers accounted for 10% or more of our revenues for the periods presented:
Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
U.S. Government 20 % 12 % 20 % 11 %
Quick Laser Technology Co., Ltd. (1) 15 % (1) 12 %
Raytheon Technologies (1) 11 % (1) 13 %
(1) Represents less than 10% of total revenues

Financial instruments that potentially expose us to concentrations of credit risk consist principally of accounts receivable. As of June 30, 2021 and December 31, 2020, two customers accounted for approximately 34 % and 43 %, respectively, of net accounts receivable. No other customers accounted for 10% or more of net accounts receivable at either date.

Note 5 - Fair Value of Financial Instruments

The carrying amounts of certain of our financial instruments, including cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities are shown at cost which approximates fair value due to the short-term nature of these instruments. The fair value of our term and revolving loans approximates the carrying value due to the variable market rate used to calculate interest payments.
We do not have any other significant financial assets or liabilities that are measured at fair value.
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The standard describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value which are the following:
• Level 1 Inputs: Observable inputs, such as quoted prices (unadjusted) in active markets for identical assets or liabilities at the measurement date.
• Level 2 Inputs: Observable inputs, other than Level 1 prices, such as quoted prices in active markets for similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
• Level 3 Inputs: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Our financial instruments that are carried at fair value consist of Level 1 assets which include highly liquid investments and bank drafts classified as cash equivalents. Our fair value hierarchy for our financial instruments consists of cash equivalents as follows (in thousands):
June 30, 2021
Level 1 Level 2 Level 3 Total
Money market securities $ 156,893 $ — $ — $ 156,893
Commercial paper 1,873 — — 1,873
Total $ 158,766 $ — $ — $ 158,766
9
December 31, 2020
Level 1 Level 2 Level 3 Total
Money market securities $ 74,084 $ — $ — $ 74,084
Commercial paper 1,584 — — 1,584
Total $ 75,668 $ — $ — $ 75,668


Note 6 - Inventory
Inventory is stated at the lower of average cost (principally standard cost, which approximates actual cost on a first-in, first-out basis) and net realizable value. Inventory includes raw materials and components that may be specialized in nature and subject to obsolescence. On a quarterly basis, we review inventory quantities on hand in comparison to our past consumption, recent purchases, and other factors to determine what inventory quantities, if any, may not be sellable. Based on this analysis, we write down the affected inventory value for estimated excess and obsolescence charges. At the point of loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Inventory consisted of the following (in thousands):
As of
June 30, 2021 December 31, 2020
Raw materials $ 25,289 $ 21,410
Work in process and semi-finished goods 23,061 21,320
Finished goods 14,946 11,976
$ 63,296 $ 54,706

Note 7 - Property, Plant and Equipment
Property, plant and equipment consist of the following (in thousands):
As of
Useful life (years) June 30, 2021 December 31, 2020
Automobile 3 $ 113 $ 34
Computer hardware and software
3 - 5
5,806 4,840
Manufacturing and lab equipment
2 - 7
73,360 69,849
Office equipment and furniture
5 - 7
1,849 1,605
Leasehold and building improvements
2 - 12
25,675 21,934
Buildings 30 9,392 9,081
Land N/A 3,399 3,399
119,594 110,742
Accumulated depreciation ( 70,216 ) ( 66,262 )
$ 49,378 $ 44,480

10
Note 8 - Intangible Assets and Goodwill
Intangibles
The details of amortizing intangible assets are as follows (in thousands, except for estimated useful lives):
Estimated useful life
(in years) 		As of
June 30, 2021 December 31, 2020
Patents
3 - 5
$ 5,887 $ 6,199
Development programs
2 - 4
7,200 7,200
Developed technology 5 1,125 1,226
14,212 14,625
Accumulated amortization ( 7,693 ) ( 6,280 )
$ 6,519 $ 8,345

Estimated amortization expense for future years is as follows (in thousands):
Remainder of 2021 $ 1,883
2022 2,402
2023 1,720
2024 378
2025 136
$ 6,519

Goodwill
The carrying amount of goodwill by segment was as follows (in thousands):
Laser Products Advanced Development Totals
Balance, December 31, 2020 $ 2,236 $ 10,248 $ 12,484
Currency exchange rate adjustment ( 27 ) — ( 27 )
Balance, June 30, 2021 $ 2,209 $ 10,248 $ 12,457


Note 9 - Accrued Liabilities
Accrued liabilities consist of the following (in thousands):
As of
June 30, 2021 December 31, 2020
Accrued payroll and benefits $ 12,293 $ 10,770
Product warranty, current 2,246 2,122
Income tax payable 53 401
Other accrued expenses 972 2,028
$ 15,564 $ 15,321



11
Note 10 - Product Warranties
We provide warranties on certain products and record a liability for the estimated future costs associated with warranty claims at the time revenue is recognized. The warranty liability is based on historical experience, any specifically identified failures, and our estimate of future costs.

Product warranty liability activity was as follows for the periods presented (in thousands):
Six Months Ended June 30,
2021 2020
Product warranty liability, beginning $ 4,711 $ 2,984
Warranty charges incurred, net ( 1,132 ) ( 1,531 )
Provision for warranty charges, net of adjustments 1,779 2,271
Acquired warranty — 100
Product warranty liability, ending 5,358 3,824
Less: current portion of product warranty liability ( 2,246 ) ( 1,918 )
Non-current portion of product warranty liability $ 3,112 $ 1,906

Note 11 - Commitments and Contingencies

Leases
See Note 12.

Legal Matters
From time to time, we may be subject to legal proceedings and claims in the ordinary course of business. As of June 30, 2021, and as of the filing of this Quarterly Report on Form 10-Q, we were not involved in any material legal proceedings.

Note 12 - Leases

We lease real estate space under non-cancelable operating lease agreements for commercial and industrial space. Facilities-related operating leases have remaining terms of 0.3 to 13.9 years, and some leases include options to extend up to 15 years. Other leases for automobiles, manufacturing and office and computer equipment have remaining lease terms of 0.1 to 4.9 years. These leases are primarily operating leases; financing leases are not material. We did not include any renewal options in our lease terms for calculating the lease liabilities as we are not reasonably certain we will exercise the options at this time. The weighted-average remaining lease term for the lease obligations was 9 years at June 30, 2021, and the weighted-average discount rate was 3.6 %.

The components of lease expense related to operating leases were as follows (in thousands):
Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
Lease expense:
Operating lease expense $ 1,092 $ 651 $ 1,966 $ 1,420
Short-term lease expense 210 31 283 118
Variable and other lease expense 235 107 357 253
$ 1,537 $ 789 $ 2,606 $ 1,791


12
Future minimum payments under our non-cancelable lease obligations were as follows as of June 30, 2021 (in thousands):
Remainder of 2021 $ 1,819
2022 3,299
2023 2,479
2024 2,345
2025 1,896
Thereafter 10,011
Total minimum lease payments 21,849
Less: interest ( 3,423 )
Present value of net minimum lease payments 18,426
Less: current portion of lease liabilities ( 2,921 )
Total long-term lease liabilities $ 15,505

Note 13 - Stockholders' Equity and Stock-Based Compensation

Public Offering
In March 2021, we closed a follow-on public offering in which we issued and sold approximately 2.5 million shares of common stock (including approximately 0.3 million shares sold pursuant to the full exercise of the underwriters option to purchase additional shares) at an offering price of $ 34.00 per share, resulting in aggregate net proceeds to us of approximately $ 82.4 million after deducting underwriting discounts, commissions and offering costs.

Restricted Stock Awards and Units
Restricted stock award (RSA) and restricted stock unit (RSU) activity under our equity incentive plan was as follows (in thousands, except weighted-average grant date fair values):
Number of Restricted Stock Awards Weighted-Average Grant Date Fair Value
RSAs at December 31, 2020 653 $ 21.30
Awards granted — —
Awards vested ( 124 ) 21.88
RSAs at June 30, 2021 529 $ 21.16

Number of Restricted Stock Units Weighted-Average Grant Date Fair Value
RSUs at December 31, 2020 2,800 $ 20.54
Awards granted 125 35.12
Awards vested ( 420 ) 23.17
Awards forfeited ( 19 ) 22.51
RSUs at June 30, 2021 2,486 $ 20.81

The total fair value of RSAs and RSUs vested during the six months ended June 30, 2021 was $ 2.7 million and $ 9.7 million, respectively. Awards outstanding as of June 30, 2021 include 0.7 million performance-based awards that will vest upon meeting certain performance criteria.


13
Stock Options
The following table summarizes our stock option activity during the six months ended June 30, 2021 (in thousands, except weighted-average exercise prices):
Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value
Outstanding, December 31, 2020 3,358 $ 1.53 5.3 $ 104,510
Options exercised ( 553 ) $ 1.39
Options canceled ( 2 ) $ 4.10
Outstanding, June 30, 2021 2,803 $ 1.55 4.9 $ 97,345
Options exercisable at June 30, 2021 2,416 $ 1.18 4.7 $ 84,789
Options vested as of June 30, 2021 and expected to vest after June 30, 2021 2,803 $ 1.55 4.9 $ 97,345

Total intrinsic value of options exercised for the six months ended June 30, 2021 and 2020 was $ 17.8 million and $ 8.8 million, respectively. We received proceeds of $ 0.8 million and $ 0.9 million from the exercise of options for each of the six months ended June 30, 2021 and 2020.

Employee Stock Purchase Plan
Information related to activity under our Employee Stock Purchase Plan (ESPP) was as follows (in thousands, except weighted average per share prices):

Six Months Ended June 30, 2021
Shares issued 33
Weighted-average per share purchase price $ 22.41
Weighted-average per share discount from the fair value of our common stock on date of issuance $ 3.95

Stock-Based Compensation
Total stock-based compensation expense was included in our consolidated statements of operations as follows (in thousands):
Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
Cost of revenues $ 549 $ 339 $ 1,040 $ 684
Research and development 3,708 2,275 6,626 4,057
Sales, general and administrative 7,349 3,423 11,994 5,059
$ 11,606 $ 6,037 $ 19,660 $ 9,800

Unrecognized Compensation Costs
As of June 30, 2021, total unrecognized stock-based compensation was $ 53.2 million, which will be recognized over an average expected recognition period of 2.3 years.

Common Stock Repurchase Plan
On November 14, 2019, our Board of Directors authorized the repurchase of up to $ 10.0 million of our outstanding shares of common stock. As of June 30, 2021, no repurchases had been executed under the program.

14
Note 14 - Segment Information

We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment. The following table summarizes the operating results by reportable segment for the periods presented (dollars in thousands):
Three Months Ended June 30, 2021
Laser Products Advanced Development Corporate and Other Totals
Revenue $ 53,561 $ 15,552 $ — $ 69,113
Gross profit $ 19,871 $ 1,004 $ ( 550 ) $ 20,325
Gross margin 37.1 % 6.5 % NM 29.4 %
Six Months Ended June 30, 2021
Laser Products Advanced Development Corporate and Other Totals
Revenue $ 100,896 $ 29,562 $ — $ 130,458
Gross profit $ 37,302 $ 1,709 $ ( 1,041 ) $ 37,970
Gross margin 37.0 % 5.8 % NM 29.1 %
Three Months Ended June 30, 2020
Laser Products Advanced Development Corporate and Other Totals
Revenue $ 45,104 $ 7,034 $ — $ 52,138
Gross profit $ 12,846 $ 549 $ ( 339 ) $ 13,056
Gross margin 28.5 % 7.8 % NM 25.0 %
Six Months Ended June 30, 2020
Laser Products Advanced Development Corporate and Other Totals
Revenue $ 82,034 $ 13,319 $ — $ 95,353
Gross profit $ 22,221 $ 1,020 $ ( 684 ) $ 22,557
Gross margin 27.1 % 7.7 % NM 23.7 %

Corporate and Other is unallocated expenses related to stock-based compensation.

There have been no material changes to the geographic locations of our long‑lived assets, net, based on the location of the assets, as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020.

Note 15 - Net Loss per Share

Basic and diluted net loss and the number of shares used for basic and diluted net loss calculations were the same for all period presented because we were in a loss position.

The following potentially dilutive securities were not included in the calculation of diluted shares as the effect would have been anti‑dilutive (in thousands):

Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
Restricted stock units and awards 2,057 2,293 2,182 2,260
Employee stock purchase plan 3 20 6 —
Common stock options 2,803 3,711 2,803 3,711
4,863 6,024 4,991 5,971

15
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "ability," "anticipate," "attempt," "believe," "can be," "continue," "could," "depend," "enable," "estimate," "expect," "extend," "grow," "if," "intend," "likely," "may," "objective," "ongoing," "plan," "possible," "potential," "predict," "project," "propose," "rely," "should," "target," "will," "would" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.

These statements involve risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements include, but are not limited to, statements about: our ability to develop new technology, designs and applications for our lasers; the implementation of our business model and strategic plans, including estimates regarding future sales, revenues, expenses, acquisitions, investments and capital requirements; our future financial performance; our utilization of vertical integration; our ability to adequately protect our intellectual property rights; the effect on our business of litigation to which we are or may become a party; and the sufficiency of our existing liquidity sources to meet our cash needs; and our ability to sustain and manage growth in our business.

You should refer to the "Risk Factors" section of this report and those risk factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2020 for a discussion of other important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this report will prove to be accurate. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report, which although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Overview
nLIGHT, Inc., is a leading provider of high‑power semiconductor and fiber lasers for industrial, microfabrication, and aerospace and defense applications. Headquartered in Camas, Washington, we design, develop and manufacture the critical elements of our lasers, and believe our vertically integrated business model enables us to rapidly introduce innovative products, control our costs and protect our intellectual property.

We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment. Sales of our semiconductor lasers, fiber lasers and directed energy products are included in the Laser Products segment, while revenue earned from research and development contracts are included in the Advanced Development segment.

Revenues increased to $130.5 million in the six months ended June 30, 2021 compared to $95.4 million in the same period of 2020 as a result of higher revenue across all end markets. We generated a net loss of $14.0 million for the six months ended June 30, 2021 compared to a net loss of $14.3 million for the same period of 2020.


16
Factors Affecting Our Performance

For factors affecting our performance, reference is made to Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," contained in Part II of our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to the factors affecting our performance since December 31, 2020.

Results of Operations

The following table sets forth our operating results as a percentage of revenues for the periods indicated:
Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
Revenue:
Products 77.5 % 86.5 % 77.3 % 86.0 %
Development 22.5 13.5 22.7 14.0
Total revenue 100.0 100.0 100.0 100.0
Cost of revenue:
Products 49.5 62.5 49.5 63.4
Development 21.1 12.5 21.4 12.9
Total cost of revenue 70.6 75.0 70.9 76.3
Gross profit 29.4 25.0 29.1 23.7
Operating expenses:
Research and development 20.7 18.1 19.9 18.9
Sales, general, and administrative 21.8 18.5 20.5 18.2
Total operating expenses 42.5 36.6 40.4 37.1
Loss from operations (13.1) (11.6) (11.3) (13.4)
Other income (expense):
Interest income (expense), net — (0.1) (0.1) 0.2
Other income (expense), net 0.2 (0.6) 0.1 (0.4)
Loss before income taxes (12.9) (12.3) (11.3) (13.6)
Income tax expense (benefit) (1.5) 0.8 (0.5) 1.4
Net loss (11.4) % (13.1) % (10.8) % (15.0) %

Revenues by Segment

Our revenues by segment were as follows for the periods presented (dollars in thousands):
Three Months Ended June 30, Change
2021 % of Revenue 2020 % of Revenue $ %
Laser Products $ 53,561 77.5 % $ 45,104 86.5 % $ 8,457 18.8 %
Advanced Development 15,552 22.5 7,034 13.5 8,518 121.1
$ 69,113 100.0 % $ 52,138 100.0 % $ 16,975 32.6 %

Six Months Ended June 30, Change
2021 % of Revenue 2020 % of Revenue $ %
Laser Products $ 100,896 77.3 % $ 82,034 86.0 % $ 18,862 23.0 %
Advanced Development 29,562 22.7 13,319 14.0 16,243 122.0
$ 130,458 100.0 % $ 95,353 100.0 % $ 35,105 36.8 %

17
The increase in Laser Products revenue for the three and six months ended June 30, 2021, compared to the same period of 2020, was driven by increased sales from the Industrial and Microfabrication markets as discussed below. The increase in Advanced Development revenue was primarily due to increased activity on existing research and development contracts.

Revenues by End Market

Our revenues by end market were as follows for the periods presented (dollars in thousands):
Three Months Ended June 30, Change
2021 % of Revenue 2020 % of Revenue $ %
Industrial $ 24,907 36.1 % $ 22,630 43.4 % $ 2,277 10.1 %
Microfabrication 20,274 29.3 14,300 27.4 5,974 41.8
Aerospace and Defense 23,932 34.6 15,208 29.2 8,724 57.4
$ 69,113 100.0 % $ 52,138 100.0 % $ 16,975 32.6 %

Six Months Ended June 30, Change
2021 % of Revenue 2020 % of Revenue $ %
Industrial $ 46,307 35.5 % $ 38,620 40.5 % $ 7,687 19.9 %
Microfabrication 35,489 27.2 24,719 25.9 10,770 43.6
Aerospace and Defense 48,662 37.3 32,014 33.6 16,648 52.0
$ 130,458 100.0 % $ 95,353 100.0 % $ 35,105 36.8 %

The increases in revenue from the Industrial market for the three and six months ended June 30, 2021, compared to the same period of 2020, were driven by increases in unit sales, partially offset by lower average selling prices due to changes in product mix. The increases in revenue from the Microfabrication market for the three and six months ended June 30, 2021, compared to the same periods of 2020, were driven by increases in demand and unit sales of semiconductor lasers. The increases in revenue from the Aerospace and Defense market for the three and six months ended June 30, 2021, compared to the same periods of 2020, were primarily due to increased activity on existing research and development contracts.

Revenues by Geographic Region

Our revenues by geographic region were as follows for the periods presented (dollars in thousands):
Three Months Ended June 30, Change
2021 % of Revenue 2020 % of Revenue $ %
North America $ 33,095 47.9 % $ 20,494 39.3 % $ 12,601 61.5 %
China 18,759 27.1 21,495 41.2 (2,736) (12.7)
Rest of World 17,259 25.0 10,149 19.5 7,110 70.1
$ 69,113 100.0 % $ 52,138 100.0 % $ 16,975 32.6 %

Six Months Ended June 30, Change
2021 % of Revenue 2020 % of Revenue $ %
North America $ 64,229 49.2 % $ 41,540 43.6 % $ 22,689 54.6 %
China 34,336 26.3 33,537 35.2 799 2.4
Rest of World 31,893 24.4 20,276 21.2 11,617 57.3
$ 130,458 100.0 % $ 95,353 100.0 % $ 35,105 36.8 %

18
Geographic revenue information is based on the location to which we ship our products. The increases in North America revenue for the three and six months ended June 30, 2021, compared to the same periods of 2020, were primarily driven by increased revenue from the Aerospace and Defense market. The decrease in China revenue for the three months ended June 30, 2021, compared to the same period of 2020, was primarily due to decreased sales in the Industrial market, while the increase in China revenue for the six months ended June 30, 2021, compared to the same period of 2020, was driven by higher sales in all markets. The increases in Rest of World revenue for the three and six months ended June 30, 2021, compared to the same periods of 2020, were primarily due to increased sales in the Microfabrication market.

Cost of Revenues and Gross Margin

Cost of Laser Products revenue consists primarily of manufacturing materials, payroll, shipping and handling costs, tariffs and manufacturing-related overhead. We order materials and supplies based on backlog and forecasted customer orders. We expense all warranty costs and inventory provisions as cost of revenues. Cost of Advanced Development revenue consists of materials, labor, subcontracting costs, and an allocation of indirect costs including overhead and general and administrative.

Our gross profit and gross margin were as follows for the periods presented (dollars in thousands):
Three Months Ended June 30, 2021
Laser Products Advanced Development Corporate and Other Total
Gross profit $ 19,871 $ 1,004 $ (550) $ 20,325
Gross margin 37.1 % 6.5 % NM 29.4 %
Six Months Ended June 30, 2021
Laser Products Advanced Development Corporate and Other Total
Gross profit $ 37,302 $ 1,709 $ (1,041) $ 37,970
Gross margin 37.0 % 5.8 % NM 29.1 %
Three Months Ended June 30, 2020
Laser Products Advanced Development Corporate and Other Total
Gross profit $ 12,846 $ 549 $ (339) $ 13,056
Gross margin 28.5 % 7.8 % NM 25.0 %
Six Months Ended June 30, 2020
Laser Products Advanced Development Corporate and Other Total
Gross profit $ 22,221 $ 1,020 $ (684) $ 22,557
Gross margin 27.1 % 7.7 % NM 23.7 %

The increases in Laser Products gross margin for the three and six months ended June 30, 2021, compared to the same periods of 2020, were driven primarily by sales mix, product cost improvements, and improved factory utilization from higher production volume. The decreases in Advanced Development gross margin for the three and six months ended June 30, 2021, compared to the same periods of 2020, were primarily due to changes in the composition of research and development contracts.


19
Operating Expenses

Our operating expenses were as follows for the periods presented (dollars in thousands):

Research and Development
Three Months Ended June 30, Change
2021 2020 $ %
Research and development $ 14,282 $ 9,472 $ 4,810 50.8 %

Six Months Ended June 30, Change
2021 2020 $ %
Research and development $ 25,992 $ 18,010 $ 7,982 44.3 %

The increases in research and development expense for the three and six months ended June 30, 2021, compared to the same periods in 2020, were primarily due to increases in stock-based compensation of $1.4 million and $2.6 million, respectively, and increased employee costs and project-related expenses to support our development efforts.

Sales, General and Administrative
Three Months Ended June 30, Change
2021 2020 $ %
Sales, general, and administrative $ 15,057 $ 9,633 $ 5,424 56.3 %

Six Months Ended June 30, Change
2021 2020 $ %
Sales, general, and administrative $ 26,771 $ 17,333 $ 9,438 54.5 %

The increases in sales, general and administrative expense for the three and six months ended June 30, 2021, compared to the same periods in 2020 were primarily due to increase in stock-based compensation of $3.9 million and $6.9 million, respectively, and increased employee costs and professional service fees to support our continued growth.

Interest Income (Expense), net
Three Months Ended June 30, Change
2021 2020 $ %
Interest income (expense), net $ (32) $ (65) $ 33 50.8%

Six Months Ended June 30, Change
2021 2020 $ %
Interest income (expense), net $ (106) $ 218 $ (324) (148.6)%

The changes in interest income (expense), net, for the three and six months ended June 30, 2021, compared to the same periods in 2020 were primarily attributable to decreases in the market rates on money market funds, offset partially by the March 2021 cash infusion from our public offering of stock.

Other Income (Expense), net
Three Months Ended June 30, Change
2021 2020 $ %
Other income (expense), net $ 118 $ (298) $ 416 139.6%

20
Six Months Ended June 30, Change
2021 2020 $ %
Other income (expense), net $ 144 $ (414) $ 558 134.8%

The increases in other income (expense), net for the three and six months ended June 30, 2021, compared to the same periods in 2020 were primarily attributable to changes in net realized and unrealized foreign exchange transactions resulting from currency rate fluctuations.

Income Tax Expense (Benefit)
Three Months Ended June 30, Change
2021 2020 $ %
Income tax expense (benefit) $ (1,038) $ 418 $ (1,456) (348.3) %

Six Months Ended June 30, Change
2021 2020 $ %
Income tax expense (benefit) $ (716) $ 1,323 $ (2,039) (154.1) %

We record income tax expense for taxes in our foreign jurisdictions including Finland, Italy and Korea. We also record tax expense for uncertain tax positions taken and associated penalties and interest. We consider all available evidence, both positive and negative, in assessing the extent to which a valuation allowance should be applied against our deferred tax assets. Due to the uncertainty with respect to their ultimate realizability in the U.S. and China, we continue to maintain a full valuation allowance in both jurisdictions as of June 30, 2021.

The decreases in income tax expense for the three and six months ended June 30, 2021, compared to the same periods in 2020 were driven by decreases in income from our Finland operations and a discrete tax benefit related to return to provision true ups and expiring statue of limitation of unrecognized tax positions. Our tax expense is dependent on the geographic mix of earnings and primarily related to our foreign operations.

Liquidity and Capital Resources

We had cash and cash equivalents of $175.4 million and $102.3 million as of June 30, 2021 and December 31, 2020, respectively.

For the six months ended June 30, 2021, our principal uses of liquidity were to fund our working capital needs. Our principal sources of liquidity for the six months ended June 30, 2021 was from our equity offering and cash flows from operations.

We believe our existing sources of liquidity will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. However, we may need to raise additional capital to expand the commercialization of our products, fund our operations and further our research and development activities. Our future capital requirements may vary materially from period to period and will depend on many factors, including the timing and extent of spending on research and development efforts, the expansion of sales and marketing activities, the continuing market acceptance of our products and ongoing investments to support the growth of our business. We may in the future enter into arrangements to acquire or invest in complementary businesses, services, technologies and intellectual property rights. From time to time, we may explore additional financing sources which could include equity, equity‑linked and debt financing arrangements.

21
The following table summarizes our cash flows for the periods presented (in thousands):
Six Months Ended June 30,
2021 2020
Net cash provided by operating activities $ 3,085 $ 7,002
Net cash used in investing activities (8,469) (17,668)
Net cash provided by financing activities 78,551 14,340
Effect of exchange rate changes on cash (126) (27)
Net increase in cash, cash equivalents and restricted cash $ 73,041 $ 3,647

Net Cash Provided by Operating Activities

During the six months ended June 30, 2021, net cash provided by operating activities was $3.1 million, which was primarily driven by non‑cash expenses totaling $28.6 million related to depreciation and amortization, stock-based compensation, and other items, a $3.3 million increase in accounts payable and a $1.3 million increase in accrued and other long-term liabilities. These items were partially offset by our net loss of $14.0 million and increases of $8.6 million in inventory and $4.8 million in accounts receivable. The increase in inventory was driven primarily by an expected increase in future period sales, the increase in accounts receivable was attributable to the increase in revenue and timing of shipments during the quarter, and the increase in accounts payable was attributable to the increase in inventory and the timing of vendor payments.
During the six months ended June 30, 2020, net cash provided by operating activities was $7.0 million, which was primarily driven by non-cash expenses totaling $17.7 million related to depreciation and amortization, stock-based compensation, and other items, a $7.4 million increase in accounts payable and a $3.0 million decrease in account receivable. These items were partially offset by our net loss of $14.3 million, a $4.5 million increase in inventory, a $1.8 million increase in prepaid expenses and other current assets and a $2.1 million increase in other assets. The increase in inventory supported new product introductions, decreased customer lead times and increased safety stock. The increase in accounts payable was primarily driven by the timing of vendor payments.

Net Cash Used in Investing Activities

During the six months ended June 30, 2021, net cash used in investing activities was $8.5 million, primarily resulting from $8.0 million of capital expenditures related to investments in manufacturing equipment and improvements to our corporate facility.

During the six months ended June 30, 2020, net cash used in investing activities was $17.7 million, primarily resulting from $17.0 million of capital expenditures related to the acquisition of commercial property and other investments in manufacturing equipment for our worldwide operations.

Net Cash Provided by Financing Activities

During the six months ended June 30, 2021, net cash provided by financing activities was $78.6 million, which was primarily driven by our follow-on public offering of $82.4 million, net of offering costs, and $1.5 million of proceeds from stock options exercises and employee stock program purchases, partially offset by $4.6 million of withholding tax payments related to the vesting of stock awards.

During the six months ended June 30, 2020, net cash provided by financing activities was $14.3 million, which was primarily driven by proceeds from our revolving line of credit of $15.0 million to acquire commercial property, and $1.5 million of proceeds from stock options exercises and employee stock program purchases, offset by $2.2 million of withholding tax payments related to the vesting of stock awards.


22
Credit Facilities

We have a $40.0 million revolving line of credit with Pacific Western Bank which is secured by our assets and expires in September 2021. Interest on the line of credit is based primarily on the London Interbank Offered Rate (LIBOR), or an alternative rate such as the Prime rate, plus or minus, respectively, a margin based on certain liquidity levels. The loan agreement contains restrictive and financial covenants and bears an unused credit fee of 0.20% on an annualized basis. As of June 30, 2021, no amounts were outstanding under the line of credit, and we were in compliance with all covenants under the loan agreement.

Contractual Obligations

For the six months ended June 30, 2021, our operating lease obligations increased by approximately $5.8 million. There have been no other material changes to our contractual obligations as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020.

Off-Balance Sheet Arrangements

Since inception, we have not had any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or for another contractually narrow or limited purpose.

Inflation

While we do not believe that inflation had a material effect on our business, financial condition or results of operations through June 30, 2021, we experienced wage and benefits increases during the three months ended June 30, 2021. We expect that those increases will continue to impact our labor costs. If our costs, including labor costs, were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could materially adversely affect our business, financial condition and results of operations.

Recent Accounting Pronouncements

See Note 1 of Notes to Consolidated Financial Statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
For financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” contained in Part II of our Annual Report on Form 10-K for the year ended December 31, 2020. Our exposure to market risk has not changed materially since December 31, 2020.

ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our chief executive officer and our chief financial officer, have evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our chief executive officer and our chief financial officer have concluded that, as of such date, our disclosure controls and procedures were, in design and operation, effective.

Changes in Internal Control over Financial Reporting

Our chief executive officer and our chief financial officer did not identify any changes in our internal control over financial reporting in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act during the three months ended June 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


23
Limitations on the Effectiveness of Internal Control

Control systems, including ours, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any control systems must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. Control systems can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based, in part, on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business, but cannot assure you that such improvements will be sufficient to provide us with effective internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We may, from time to time, be party to litigation and subject to claims incident to the ordinary course of business. As our company matures, we may become party to an increasing number of litigation matters and claims. The outcome of litigation and claims cannot be predicted with certainty, and the resolution of these matters could materially adversely affect our business, financial condition, results of operations and growth prospects.

There have been no material changes to the legal proceedings disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020.

ITEM 1A. RISK FACTORS

For risk factors related to our business, reference is made to Item 1A, "Risk Factors," contained in Part I of our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020.


24
ITEM 6. EXHIBITS

(a) Exhibits
Exhibit
Number 		Incorporated by Reference Filed
Herewith
Description Form File No. Exhibit Filing Date
3.1 10-Q 001-38462 3.1 May 25, 2018
3.2 8-K 001-38462 3.1 April 21, 2020
4.1 S-1/A 333-224055 4.1 April 16, 2018
31.1 X
31.2 X
32.1* X
101.INS Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) X
101.SCH Inline XBRL Taxonomy Extension Schema Document X
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. X
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document X
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document X
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document X
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) X
*
The certifications furnished in Exhibit 32.1 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.

25
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
NLIGHT, INC.
(Registrant)
August 6, 2021 By: /s/ SCOTT KEENEY
Date Scott Keeney
President and Chief Executive Officer
(Principal Executive Officer)
August 6, 2021 By: /s/ RAN BAREKET
Date Ran Bareket
Chief Financial Officer
(Principal Accounting and Financial Officer)

26
TABLE OF CONTENTS
Part I - Financial InformationItem 1. Unaudited Interim Financial StatementsNote 1 - Basis Of Presentation and New Accounting PronouncementsNote 2 - AcquisitionsNote 3 - RevenueNote 4 - Concentrations Of Credit and Other RisksNote 5 - Fair Value Of Financial InstrumentsNote 6 - InventoryNote 7 - Property, Plant and EquipmentNote 8 - Intangible Assets and GoodwillNote 9 - Accrued LiabilitiesNote 10 - Product WarrantiesNote 11 - Commitments and ContingenciesNote 12 - LeasesNote 13 - Stockholders' Equity and Stock-based CompensationNote 14 - Segment InformationNote 15 - Net Loss Per ShareItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II - Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 6. Exhibits

Exhibits

3.1 Amended and Restated Certificate of Incorporation of the Registrant 10-Q 001-38462 3.1 May 25, 2018 3.2 Amended and Restated Bylaws of the Registrant 8-K 001-38462 3.1 April 21, 2020 4.1 Specimen Common Stock Certificate of the Registrant S-1/A 333-224055 4.1 April 16, 2018 31.1 Certification of the Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2 Certification of the Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1* Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002